Quantcast

Latest Thalidomide Stories

2011-12-12 12:50:55

Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego. The drug thalidomide achieved infamy in the early 1960s as the cause of severe birth defects after being given to pregnant mothers for...

2011-06-15 00:00:27

BioPlus Specialty Pharmacy, one of the nation's leading specialty pharmacies, offers numerous oncology drugs as well as an oncology therapy management program that increases patient compliance. Altamonte Springs, FL (PRWEB) June 13, 2011 BioPlus Specialty Pharmacy (BioPlus), one of the nation's leading specialty pharmacies, has numerous oral oncology medications available for patients with cancer. As a specialty pharmacy, BioPlus works with patients and their physicians in oncology...

2011-05-19 07:11:00

INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma. Results from the Phase I study will be presented on Sunday, June 5 at 11:30 a.m. CDT during the Lymphoma and Plasma Cell Disorders Oral Abstract Session (Abstract #8012) at the 47th Annual Meeting of the...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related